Aom0498 (Adamgammadex) received China’s NMPA approval
Aomo Pharma Inc., the U.S. subsidiary of Adamerck, is a biotechnology company founded in 2000 with the mission of developing
A forum for researchers, students and applicants in the field of cyclodextrin technology
Aomo Pharma Inc., the U.S. subsidiary of Adamerck, is a biotechnology company founded in 2000 with the mission of developing
The photocycloaddition (PCA) of chalcones represents an important reaction pathway for accessing substituted cyclobutanes, which is a molecular framework with
This review systematically examines surfactant-assisted electrochemical technologies for degrading persistent pollutants in water, soil, and sediment, and clarifies what distinguishes
Aomo Pharma Inc., the U.S. subsidiary of Adamerck, is a biotechnology company founded in 2000 with the mission of developing
The photocycloaddition (PCA) of chalcones represents an important reaction pathway for accessing substituted cyclobutanes, which is a molecular framework with
This review systematically examines surfactant-assisted electrochemical technologies for degrading persistent pollutants in water, soil, and sediment, and clarifies what distinguishes
Gemcitabine remains a vital chemotherapeutic agent, yet its rapid deamination and short systemic persistence necessitate improved delivery strategies. This study
Realizing reliable medicine anticounterfeiting with safe and robust materials remains a challenge. A class of edible phosphorescent supramolecules (VB10@α/β-CDs) based
The 2nd International Conference on Biomedical Science and Engineering will be held in Budapest, Hungary on September 21-22, 2026. The theme “Driving Sustainable Growth Through Biomedical and
This study (1) aims to build on previously published results that characterized cholesteryl-modified β-cyclodextrin (CD21chol) as a carrier for 5-fluorouracil. (2)
Two types of hydroxypropylated CD (HPβCD and HPγCD) were used to create electrospun nanofibers with two different molar ratios (1:1
Octenyl succinic anhydride (OSA) modification is an effective strategy to improve the emulsifying properties of carbohydrates. OSA-highly branched cyclic dextrin
Traditional chitosan hydrogels are highly biocompatible but too hydrophilic to effectively load and sustain release of hydrophobic drugs. In a